Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review
RSC Medicinal Chemistry · 2026 · 17 (3) · 1252-1270
DOI: 10.1039/d5md00935a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Mateusz Klarek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemistry, University of Łódź Tamka 12 91-403 Łódź Poland kondor15@wp.pl konrad.kowalski@chemia.uni.lodz.…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Uniwersytet Łódzki.
Abstract (Originalsprache)
Ferroptosis is one of the regulated cell death pathways. Molecular mechanisms underlying ferroptosis involve iron-dependent lipid peroxidation, which results in cell-deleterious membrane damage.
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Chemistry, University of Łódź Tamka 12 91-403 Łódź Poland kondor15@wp.pl konrad.kowalski@chemia.uni.lodz.pl.
ORCID-Profile: Mateusz Klarek, Aryan Gautam, Konrad Kowalski
Förderung
- Uniwersytet Łódzki
Zitieren
APA
Klarek, M., Gautam, A., & Kowalski, K. (2026). Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review. RSC Medicinal Chemistry, 17(3), 1252-1270. https://doi.org/10.1039/d5md00935a
Vancouver
Klarek M, Gautam A, Kowalski K. Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review. RSC Medicinal Chemistry. 2026;17(3):1252-1270. doi:10.1039/d5md00935a
BibTeX
@article{Klarek2026,
author = {Klarek, Mateusz and Gautam, Aryan and Kowalski, Konrad},
title = {Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {3},
pages = {1252--1270},
doi = {10.1039/d5md00935a}
}
EUVIMED